Status: Not yet recruiting
EVAluation of Erythrocytosis PRospEctive Cohort STudy
The EValuation of ERythrocytosis pRospEctive cohort STudy (EVEREST) is a prospective study designed to shed light on these key questions in the diagnosis, management, and clinical outcomes in patients with elevated hemoglobin (erythrocytosis). This longitudinal, prospective study will generate high quality data that can help inform the optimal approach to diagnosis and management in this patient population.
Participants needed: 1,500
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Cyrus HsiaUpdated: Jan 21, 2025Locations: 1Duration: 5 Years
Eligibility criteria
Adult patients (>=18 years) referred to hematology clinics at London Health Scie... [+2]
Patients <18 years. [+2]